Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Spatial analysis of leprosy in Lampung

Sari N, Nurmala E. Jurnal dunia kesmas. 2019;
Download PDF
Publication

Serum Iron, Total Iron Binding Capacity and Transferrin Saturation Levels in Leprosy Patients before Multi Drug Therapy - World Health Organization (MDT-WHO) Compared with Healthy Control Group

RimaTamara R, SriVitayaniMuchtar S, SafruddinAmin S, et al. ScopeMed Publishing. International Journal of Medical Reviews and Case Reports. 2018;
Download PDF
Publication

Qualitative exploration of the experiences of individual living with health-related stigma and its consequences among Indonesians with HIV, leprosy, schizophrenia, and diabetes

Rai S, Irwanto , Peters R, et al. National public health journal. 2020;
Download PDF
Publication

National Leprosy Strategy 2016-2020 - Accelerating towards a leprosy-free Sri Lanka

Ministry of Health, Nutrition and Indigenous Medicine. 2;
Download PDF
Publication

Reply to: Single-dose rifampicin and BCG to prevent leprosy.

Richardus JH, Geluk A, trial A. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;
Download PDF
Publication

"Buruli ulcer and leprosy, they are intertwined": Patient experiences of integrated case management of skin neglected tropical diseases in Liberia.

Prochazka M, Timothy J, Pullan R, et al. PLoS neglected tropical diseases. 2020; 14 (2) : e0008030.
Download PDF
Publication

Factsheet The Gender Dimensions of Neglected Tropical Diseases

Partnership T. The Access and Delivery Partnership. 2019;
Download PDF
Publication

Implementation barriers for mHealth for non-communicable diseases prevention and management in low and middle income countries: a scoping review and field-based views from implementers

Van Olmen J, Erwin E, García-Ulloa A, et al. F1000 Research Ltd. Wellcome Open Research. 2020;
Download PDF
Publication

[Initial epidemiological data on the possible preventive action of oral BCG in close contacts of leprosy patients].

BECHELLI L, QUAGLIATO R. Revista brasileira de leprologia. 1956; 24 (1-2) : 23-36.
Download PDF
Publication

Aplicabilidade do instrumento “Screening of Activity Limitation and Safety Awareness” em idosos com hanseníase

Nogueira P, Barbosa RGB, Almeida PCD, et al. FapUNIFESP (SciELO). Escola Anna Nery. 2020;

Pagination

  • Previous page ‹‹
  • Page 396
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD